Durham oncology firm lands $45M in new financing
CoImmune, which formerly was known as Argos Therapeutics, has closed on $45 million to help fund its efforts to combat cancer with immunotherapy.
Read More
coimmune
Durham biotech CoImmune (formerly Argos) acquires cancer-focused pharma
CoImmune, the name for the former Argos Therapeutics which was acquired by two South Korean firms last year, is growing larger.
Read More
